News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Nanobac Life Sciences, Inc. Announces Collaboration Agreement With BioChemics, Inc. for Transdermal Therapeutic Formulation


3/25/2008 9:38:47 AM

TAMPA, FL--(Marketwire - March 25, 2008) - Nanobac Pharmaceuticals, Inc. (OTCBB: NNBP) ("Nanobac" or "the Company") is pleased to announce the signing of a research collaboration agreement with BioChemics Inc. (BCI) to utilize BCI's leading patented drug delivery technology (VALEĀ®) for the transdermal (topical) delivery of Nanobac compounds for the treatment of prostatitis. Terms of the deal include upfront payments already made, future payments, R&D support as well as milestones for success for BCI.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES